<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Azhakesan A</submitter><funding>German Excellence Strategy</funding><funding>Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg</funding><funding>Deutsche Forschungsgemeinschaft</funding><pagination>e2403114</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11912098</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(7)</volume><pubmed_abstract>Head and neck squamous cell carcinoma (HNSCC) are invasive solid tumors accounting for high mortality. To improve the clinical outcome, a better understanding of the tumor and its microenvironment (TME) is crucial. Three -dimensional (3D) bioprinting is emerging as a powerful tool for recreating the TME in vitro. To establish long-term HNSCC bioprinted constructs for personalized drug-testing, this proof-of-principle study aims to compare two different innovative tunicate-derived nanocellulose (NC) hydrogels against the widely used semi-synthetic gelatin methacryloyl (GelMA). Cell lines of different tumor origin sites are printed in TEMPO and Carboxy-NC, and GelMA in alginate (GelMAA). Both NC hydrogels show higher bioprintability than GelMAA. Carboxy-NC supported long-term HNSCC survival,</pubmed_abstract><journal>Advanced healthcare materials</journal><pubmed_title>3D Bioprinted Head and Neck Squamous Cell Carcinoma (HNSCC) Model Using Tunicate Derived Nanocellulose (NC) Bioink.</pubmed_title><pmcid>PMC11912098</pmcid><funding_grant_id>BW6_07</funding_grant_id><funding_grant_id>RTG 2154</funding_grant_id><funding_grant_id>33‐7533‐6‐1522 / 10/4</funding_grant_id><funding_grant_id>33-7533-6-1522 / 10/4</funding_grant_id><funding_grant_id>2082/1-390761711 (3D Matter Made to Order)</funding_grant_id><pubmed_authors>Kern J</pubmed_authors><pubmed_authors>Rotter N</pubmed_authors><pubmed_authors>Selhuber-Unkel C</pubmed_authors><pubmed_authors>Azhakesan A</pubmed_authors><pubmed_authors>Mishra A</pubmed_authors><pubmed_authors>Gatenholm P</pubmed_authors><pubmed_authors>Bieback K</pubmed_authors><pubmed_authors>Affolter A</pubmed_authors></additional><is_claimable>false</is_claimable><name>3D Bioprinted Head and Neck Squamous Cell Carcinoma (HNSCC) Model Using Tunicate Derived Nanocellulose (NC) Bioink.</name><description>Head and neck squamous cell carcinoma (HNSCC) are invasive solid tumors accounting for high mortality. To improve the clinical outcome, a better understanding of the tumor and its microenvironment (TME) is crucial. Three -dimensional (3D) bioprinting is emerging as a powerful tool for recreating the TME in vitro. To establish long-term HNSCC bioprinted constructs for personalized drug-testing, this proof-of-principle study aims to compare two different innovative tunicate-derived nanocellulose (NC) hydrogels against the widely used semi-synthetic gelatin methacryloyl (GelMA). Cell lines of different tumor origin sites are printed in TEMPO and Carboxy-NC, and GelMA in alginate (GelMAA). Both NC hydrogels show higher bioprintability than GelMAA. Carboxy-NC supported long-term HNSCC survival,</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-05T12:39:09.028Z</modification><creation>2025-04-05T12:39:09.028Z</creation></dates><accession>S-EPMC11912098</accession><cross_references><pubmed>39801216</pubmed><doi>10.1002/adhm.202403114</doi></cross_references></HashMap>